Citations

Clear

108 citation(s) found for "Singh, Siddharth".

Faculty Opinions recommendation of Outcomes of treatment for achalasia depend on manometric subtype.
Iyer, Prasad G. , Singh, Siddharth

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 8, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717976245.793471887 Get It

Faculty Opinions recommendation of Objective outcomes 14 years after laparoscopic anterior 180-degree partial versus nissen fundoplication: results from a randomized trial.
Iyer, Prasad G. , Singh, Siddharth

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | February 12, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717969251.793470524 Get It

Faculty Opinions recommendation of Meta-analysis: Barrett's oesophagus and the risk of colonic tumours.
Iyer, P. K. R., Singh, Siddharth

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 10, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717964907.793468400 Get It

Faculty Opinions recommendation of Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting patho
Iyer, Prasad G. , Singh, Siddharth

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 10, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717964880.793468347 Get It

Faculty Opinions recommendation of Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease.
Iyer, Prasad G. , Singh, Siddharth

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 10, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717964450.793468173 Get It

Metformin and risk of hepatocellular carcinoma: are statins the missing link?
Singh, Siddharth , Singh, Preet Paul

Mayo Clinic

Gut | December 22, 2012 | Volume: 62 | Issue: 6 | Pages: 951-952

10.1136/gutjnl-2012-304232 | PMID 23263525 Get It

Statins and Risk Reduction in Hepatocellular Carcinoma: Fact or Fiction?
Singh, Siddharth , Singh, Preet Paul

Mayo Clinic

Journal of Clinical Oncology | June 12, 2012 | Volume: 30 | Issue: 20 | Pages: 2569-2570

10.1200/jco.2012.43.2179 | PMID 22689810 Get It

Frailty Across the Spectrum of Ankle-Brachial Index
Singh, Siddharth , Bailey, Kent R. , Noheria, Amit , Kullo, Iftikhar J.

Mayo Clinic

Angiology | July 6, 2011 | Volume: 63 | Issue: 3 | Pages: 229-236

10.1177/0003319711413457 | PMID 21733950 Get It

We investigated the burden of frailty across the spectrum of ankle-brachial index (ABI < 0.9, 0.9 ≤ ABI < 1.1, 1.1 ≤ ABI < 1.4 and ≥1.4) using data from the National Health and Nutritional Examination Survey (NHANES) in respondents aged >50 years. Criteria used to identify frailty status included weight loss, slow walking speed, weakness, exhaustion, and low physical activity. Participants meeting 1 to 2 criteria were classified as prefrail, and those meeting ≥3 criteria were classified as frail. Prevalence of frailty in respondents with ABI < 0.9 (17.5%) and 0.9 ≤ ABI < 1.1 (6.7%) was higher than in participants with normal ABI-1.1 ≤ ABI < 1.4 (4.7%). In multivariable multinomial logistic regression models, ABI < 0.9 predicted frailty (odds ratio [OR] = 2.31, 95% confidence interval [CI] = 1.08-4.94) and prefrailty (OR = 1.36, 95% CI = 0.90-2.07). Higher prevalence of frailty was seen in participants with ABI ≥ 1.4 (7.3%), P = .39. Frailty predicted general and cardiovascular mortality in participants with ABI < 0.9. Frailty mediates increased morbidity and mortality seen in peripheral arterial disease (PAD).